Skip to main content
Erschienen in: Abdominal Radiology 8/2016

26.04.2016

Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using 18fluorine-2-deoxy-d-glucose positron emission tomography–computed tomography and serum carcinoembryonic antigen: a prospective study

verfasst von: Qi-Wen Li, Rong-Liang Zheng, Yi-Hong Ling, Qiao-Xuan Wang, Wei-Wei Xiao, Zhi-Fan Zeng, Wei Fan, Li-Ren Li, Yuan-Hong Gao

Erschienen in: Abdominal Radiology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the association between 18fluorine-2-deoxy-d-glucose positron emission tomography–computed tomography (18F-FDG PET/CT) parameters, serum carcinoembryonic antigen (CEA), and tumor response in patients with rectal cancer receiving neoadjuvant chemoradiotherapy (nCRT).

Methods

Sixty-four patients with T3-4 and/or node-positive rectal cancer receiving nCRT followed by surgery were prospectively studied. PET/CT was performed before, and in 28 patients, both before and after nCRT. The pre-/post-nCRT maximum standardized uptake (SUVmax) values, differences between pre-/post-nCRT SUVmax (∆SUVmax), response index of SUVmax (RI-SUVmax), mean standardized uptake value (SUVmean), metabolic tumor volume (MTV), total lesion glycolysis (TLG), and CEA were measured. The ability of PET/CT parameters and CEA to predict Mandard’s tumor regression grade (TRG) and pathological complete remission (pCR) were evaluated.

Results

31 patients were identified as responders (TRG 1–2), and 19 exhibited pCR. For responders, significant differences were found for ΔSUVmax (24.88 vs. 15.39 g/ml, p = 0.037), RI-SUVmax (0.76 vs. 0.63, p = 0.025), ΔSUVmean (14.43 vs. 8.65 g/ml, p = 0.029), RI-SUVmean (0.77 vs. 0.63, p = 0.011), CEA-pre (6.30 vs. 27.86 μg/L, p < 0.001), CEA-post (2.22 vs. 5.49 μg/L, p = 0.002), ΔCEA (4.08 vs. 23.13 μg/L, p < 0.001), and RI-CEA (0.25 vs. 0.55, p = 0.002). Differences between pCR and non-pCR patients were noted as RI-SUVmean (0.77 vs. 0.65, p = 0.043), MTV-pre (9.87 vs. 14.62 cm3, p = 0.045), CEA-pre (5.62 vs. 22.27 μg/L, p = 0.002), CEA-post (1.95 vs. 4.72 μg/L, p = 0.001), and ΔCEA (3.68 vs. 17.99 μg/L, p = 0.013). Receiver operating characteristic analysis revealed that RI-SUVmean exhibited the greatest accuracy in predicting responders, whereas CEA-post and ΔCEA exhibited the greatest accuracy in predicting pCR.

Conclusions

18F-FDG PET/CT parameters and CEA are accurate tools for predicting tumor response to nCRT in rectal cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sauer R, Becker H, Hohenberger W, et al. (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740CrossRefPubMed Sauer R, Becker H, Hohenberger W, et al. (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740CrossRefPubMed
2.
Zurück zum Zitat Guillem JG, Chessin DB, Cohen AM, et al. (2005) Long-term oncologic outcome following preoperative combined modality therapy and total mesorectalexcision of locally advanced rectal cancer. Ann Surg 241:829–836 (discussion 836–838)CrossRefPubMedPubMedCentral Guillem JG, Chessin DB, Cohen AM, et al. (2005) Long-term oncologic outcome following preoperative combined modality therapy and total mesorectalexcision of locally advanced rectal cancer. Ann Surg 241:829–836 (discussion 836–838)CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Habr-Gama A, de Souza PM, Ribeiro U Jr, et al. (1998) Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum 41:1087–1096CrossRefPubMed Habr-Gama A, de Souza PM, Ribeiro U Jr, et al. (1998) Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum 41:1087–1096CrossRefPubMed
4.
Zurück zum Zitat Konski A, Li T, Sigurdson E, et al. (2009) Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys 74:55–59CrossRefPubMed Konski A, Li T, Sigurdson E, et al. (2009) Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys 74:55–59CrossRefPubMed
5.
Zurück zum Zitat Chen ET, Mohiuddin M, Brodovsky H, Fishbein G, Marks G (1994) Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys 30:169–175CrossRefPubMed Chen ET, Mohiuddin M, Brodovsky H, Fishbein G, Marks G (1994) Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys 30:169–175CrossRefPubMed
6.
Zurück zum Zitat Mandard AM, Dalibard F, Mandard JC, et al. (1994) Pathologic assessment of tumour regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73:2680–2686CrossRefPubMed Mandard AM, Dalibard F, Mandard JC, et al. (1994) Pathologic assessment of tumour regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73:2680–2686CrossRefPubMed
7.
Zurück zum Zitat Maas M, Nelemans PJ, Valentini V, et al. (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11:835–844CrossRefPubMed Maas M, Nelemans PJ, Valentini V, et al. (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11:835–844CrossRefPubMed
8.
Zurück zum Zitat Habr-Gama A, Perez RO, Nadalin W, et al. (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240:711–717 (discussion 717–718)PubMedPubMedCentral Habr-Gama A, Perez RO, Nadalin W, et al. (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240:711–717 (discussion 717–718)PubMedPubMedCentral
9.
Zurück zum Zitat Kim CJ, Yeatman TJ, Coppola D, et al. (2001) Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg 234:352–358 (discussion 358–359)CrossRefPubMedPubMedCentral Kim CJ, Yeatman TJ, Coppola D, et al. (2001) Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg 234:352–358 (discussion 358–359)CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Kuo LJ, Chern MC, Tsou MH, et al. (2005) Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum 48:23–28CrossRefPubMed Kuo LJ, Chern MC, Tsou MH, et al. (2005) Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum 48:23–28CrossRefPubMed
11.
Zurück zum Zitat Buijsen J, van Stiphout RG, Menheere PP, Lammering G, Lambin P (2014) Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: a prospective, hypothesis driven study on patients with locally advanced rectal cancer. Radiother Oncol 111:237–242CrossRefPubMed Buijsen J, van Stiphout RG, Menheere PP, Lammering G, Lambin P (2014) Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: a prospective, hypothesis driven study on patients with locally advanced rectal cancer. Radiother Oncol 111:237–242CrossRefPubMed
12.
Zurück zum Zitat Maffione AM, Ferretti A, Grassetto G, et al. (2013) Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy. Eur J Nucl Med Mol Imaging 40:853–864CrossRefPubMed Maffione AM, Ferretti A, Grassetto G, et al. (2013) Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy. Eur J Nucl Med Mol Imaging 40:853–864CrossRefPubMed
13.
Zurück zum Zitat Hoffmann KT, Rau B, Wust P, et al. (2002) Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio-chemotherapy plus regional hyperthermia. Strahlenther Onkol 178:386–392CrossRefPubMed Hoffmann KT, Rau B, Wust P, et al. (2002) Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio-chemotherapy plus regional hyperthermia. Strahlenther Onkol 178:386–392CrossRefPubMed
14.
Zurück zum Zitat Denecke T, Rau B, Hoffmann KT, et al. (2005) Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging? Eur Radiol 15:1658–1666CrossRefPubMed Denecke T, Rau B, Hoffmann KT, et al. (2005) Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging? Eur Radiol 15:1658–1666CrossRefPubMed
15.
Zurück zum Zitat Calvo FA, Domper M, Matute R, et al. (2004) 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 58:528–535CrossRefPubMed Calvo FA, Domper M, Matute R, et al. (2004) 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 58:528–535CrossRefPubMed
16.
Zurück zum Zitat Niccoli-Asabella A, Altini C, De Luca R, et al. (2014) Prospective analysis of 18F-FDG PET/CT predictive value in patients with low rectal cancer treated with neoadjuvant chemoradiotherapy and conservative surgery. Biomed Res Int. doi:10.1155/2014/952843 Niccoli-Asabella A, Altini C, De Luca R, et al. (2014) Prospective analysis of 18F-FDG PET/CT predictive value in patients with low rectal cancer treated with neoadjuvant chemoradiotherapy and conservative surgery. Biomed Res Int. doi:10.​1155/​2014/​952843
17.
Zurück zum Zitat Rosenberg R, Herrmann K, Gertler R, et al. (2009) The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT. Int J Colorectal Dis 24:191–200CrossRefPubMed Rosenberg R, Herrmann K, Gertler R, et al. (2009) The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT. Int J Colorectal Dis 24:191–200CrossRefPubMed
18.
Zurück zum Zitat Choi H, Yoon HJ, Kim TS, et al. (2013) Voxel-based dual-time 18F-FDG parametric imaging for rectal cancer: differentiation of residual tumor from postchemoradiotherapy changes. Nucl Med Commun 34:1166–1173PubMedPubMedCentral Choi H, Yoon HJ, Kim TS, et al. (2013) Voxel-based dual-time 18F-FDG parametric imaging for rectal cancer: differentiation of residual tumor from postchemoradiotherapy changes. Nucl Med Commun 34:1166–1173PubMedPubMedCentral
19.
Zurück zum Zitat Maffione AM, Chondrogiannis S, Marzola MC, et al. (2014) Biological target volume overlapping segmentation system method for avoiding false-positive PET findings in assessing response to neoadjuvant chemoradiation therapy in rectal cancer. Clin Nucl Med 39:e215–e219CrossRefPubMed Maffione AM, Chondrogiannis S, Marzola MC, et al. (2014) Biological target volume overlapping segmentation system method for avoiding false-positive PET findings in assessing response to neoadjuvant chemoradiation therapy in rectal cancer. Clin Nucl Med 39:e215–e219CrossRefPubMed
20.
Zurück zum Zitat Tulchinsky H, Shmueli E, Figer A, Klausner JM, Rabau M (2008) An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer. Ann Surg Oncol 15:2661–2667CrossRefPubMed Tulchinsky H, Shmueli E, Figer A, Klausner JM, Rabau M (2008) An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer. Ann Surg Oncol 15:2661–2667CrossRefPubMed
21.
Zurück zum Zitat Kim JW, Kim HC, Park JW, et al. (2013) Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy. Int J Colorectal Dis 28:1217–1224CrossRefPubMed Kim JW, Kim HC, Park JW, et al. (2013) Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy. Int J Colorectal Dis 28:1217–1224CrossRefPubMed
22.
Zurück zum Zitat Shanmugan S, Arrangoiz R, Nitzkorski JR, et al. (2012) Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT. Ann Surg Oncol 19:2178–2185CrossRefPubMed Shanmugan S, Arrangoiz R, Nitzkorski JR, et al. (2012) Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT. Ann Surg Oncol 19:2178–2185CrossRefPubMed
23.
Zurück zum Zitat Perez RO, Habr-Gama A, São Julião GP, et al. (2014) Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging. Tech Coloproctol 18:699–708CrossRefPubMed Perez RO, Habr-Gama A, São Julião GP, et al. (2014) Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging. Tech Coloproctol 18:699–708CrossRefPubMed
24.
Zurück zum Zitat Lin JZ, Pan ZZ, Zeng ZF, Ding PR, Wan DS (2009) Multivariate analysis of clinicopathologic factors correlated with pathological complete response following preoperative radiotherapy in rectal adenocarcinoma. Ai Zheng 28:919–922PubMed Lin JZ, Pan ZZ, Zeng ZF, Ding PR, Wan DS (2009) Multivariate analysis of clinicopathologic factors correlated with pathological complete response following preoperative radiotherapy in rectal adenocarcinoma. Ai Zheng 28:919–922PubMed
25.
Zurück zum Zitat Yang KL, Yang SH, Liang WY, et al. (2013) Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery. Radiat Oncol 8:43CrossRefPubMedPubMedCentral Yang KL, Yang SH, Liang WY, et al. (2013) Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery. Radiat Oncol 8:43CrossRefPubMedPubMedCentral
Metadaten
Titel
Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using 18fluorine-2-deoxy-d-glucose positron emission tomography–computed tomography and serum carcinoembryonic antigen: a prospective study
verfasst von
Qi-Wen Li
Rong-Liang Zheng
Yi-Hong Ling
Qiao-Xuan Wang
Wei-Wei Xiao
Zhi-Fan Zeng
Wei Fan
Li-Ren Li
Yuan-Hong Gao
Publikationsdatum
26.04.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 8/2016
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0698-7

Weitere Artikel der Ausgabe 8/2016

Abdominal Radiology 8/2016 Zur Ausgabe

Classics in Abdominal Imaging

The “manta ray” pelvis

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.